— Know what they know.
Not Investment Advice

PMHS OTC

Polomar Health Services, Inc.
1W: -29.4% 1M: -60.0% 3M: +1.7% YTD: -85.0%
$0.12
-0.04 (-22.58%)
 
Weekly Expected Move ±29.2%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 36 · $3.4M mcap · 14M float · 0.027% daily turnover · Short 78% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.4M
52W Range0.065-0.7999
Volume5,200
Avg Volume3,767
Beta-1.18
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTerrence Tierney
Employees7
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2009-02-09
10940 Wilshire Boulevard
Los Angeles, CA 90024
US
212 245 3413
About Polomar Health Services, Inc.

Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Spiegel David A. 0 — 2024-10-01
Gordon Daniel Later 0 — 2024-09-30
Gordon Daniel Later 0 — 2024-09-30
Gordon Daniel Later 0 — 2024-09-30
Gordon Daniel Later 0 — 2024-09-30

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms